Masks market seen shrinking through 2030 as airborne infections rise

The Business Research Company says the global market for N95 respirators and other surgical masks is expected to fall from $10.75 billion in 2025 to $9.76 billion in 2026, then to $6.54 billion by 2030. Even with the decline, the report points to demand support from airborne disease risks, especially tuberculosis, and notes Asia-Pacific as the fastest-growing region.

Why it matters: - The masks market is moving from emergency-driven demand to a smaller, more specialized market. - The projected decline signals weaker large-scale purchasing and slower pandemic-preparedness spending. - Demand still matters in healthcare, infection control and occupational protection, where airborne disease risk remains a real factor.

What happened: - The Business Research Company released a 2026 market report on N95 respirators and other surgical masks. - The report projects the market will shrink from $10.75 billion in 2025 to $9.76 billion in 2026. - The report forecasts the market will fall further to $6.54 billion by 2030. - The report was published from London on Aug. 14, 2026. - A free sample and the full report are available through the company's published links: Free sample and Full market report.

The details: - The report says the market’s 2025-2026 decline reflects fewer airborne infectious diseases, limited healthcare infrastructure growth, slower progress in preventing hospital-acquired infections and lower emergency purchases of medical masks. - The longer-term drop is tied to reduced emphasis on pandemic preparedness, less demand outside healthcare, slower development of sustainable PPE production and lower adoption of reusable masks. - The report still points to growth pockets in high-filtration respirators, fluid-resistant surgical masks, reusable and environmentally friendly materials, automated manufacturing, and improved comfort and breathability. - N95 respirators and surgical masks are personal protective equipment designed to protect the wearer from airborne particles and liquids that could contaminate the face. - The masks come in different thicknesses and protection levels, which affects both protection and breathing comfort. - The report says rising airborne infections are supporting demand. - CDC data cited in the report show U.S. tuberculosis cases rose from 8,320 in 2022 to 9,615 in 2023. - The CDC also showed the U.S. incidence rate increased from 2.5 per 100,000 people in 2022 to 2.9 per 100,000 in 2023. - North America was the largest regional market in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report covers Asia-Pacific, Southeast Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 edition adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated key-technology and future-trend analysis.

Between the lines: - The market is no longer being lifted by pandemic-era buying patterns. - The report suggests the category is splitting into two tracks: shrinking mass demand and steadier need for higher-performance and specialized products. - The Asia-Pacific growth outlook likely reflects broader healthcare expansion and industrial demand, even as global volumes contract.

What's next: - The market is expected to keep contracting through 2030 unless airborne disease pressure or emergency procurement rebounds. - Future growth will likely depend on product innovation, manufacturing efficiency and demand for reusable or higher-filtration masks. - The company says updated report tools are meant to improve forecasting and market screening for buyers and investors.

The bottom line: - Masks remain essential protection, but the market is entering a long decline after the pandemic surge.